Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh.
Clinical trial NCT00143208 · COMPLETED
Trial details
- NCT number
- NCT00143208
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-05-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.